Although urinary tract infections (UTIs) are typically minor—albeit painful—health issues for most people, they can pose ...

Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs). In clinical trials, ...

Medically reviewed by Cordelia Nwankwo, MD Key Takeaways If your UTI symptoms continue after antibiotics, it may be due to not taking your medication correctly. Antibiotic resistance occurs when ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...

Credit: Getty Images. Results are from a meta-analysis of 33 trials involving 35,939 patients with overactive bladder. Overactive bladder treatment using antimuscarinic drugs increases the risks for ...

Urinary tract infections are common, and the risk generally increases with age. They happen when bacteria infect your urethra, bladder, or other organs in your urinary tract. In older people, UTIs ...

Antibiotics do not cause urinary tract infections (UTIs). However, research suggests there may be a link between prior use of antibiotics and a person developing an antibiotic-resistant UTI. A UTI may ...

April 24 (UPI) --The newly approved oral medication Pivya provides women with another option for treating uncomplicated urinary tract infections, the U.S. Food and Drug Administration announced ...